Valenstein Marcia, Taylor Kiran Khanujua, Austin Karen, Kales Helen C, McCarthy John F, Blow Frederic C
Department of Veterans Affairs Medical Center, Serious Mental Illness Treatment, Research, and Evaluation Center, and Department of Psychiatry, University of Michigan, Ann Arbor, MI, USA. marciav@umich..edu
Am J Psychiatry. 2004 Apr;161(4):654-61. doi: 10.1176/appi.ajp.161.4.654.
Most depression treatment guidelines emphasize treatment with antidepressant medication and recommend that benzodiazepine use be minimized, particularly among elderly patients. However, little is known about patterns of benzodiazepine use in specialty mental health settings. The authors examined benzodiazepine use among a large sample of depressed patients treated in U.S. Department of Veterans Affairs (VA) mental health settings.
The VA National Registry for Depression was used to identify patients treated for depression in specialty mental health settings in 129 VA facilities during the first 3 months of fiscal year 2001 (October 1 to December 31, 2000) (N=128,029). The VA pharmacy database was used to identify outpatients who filled a prescription for benzodiazepines. The authors report on the prevalence and patterns of outpatient benzodiazepine use during the study year (fiscal year 2001) and evaluate patient demographic and clinical factors associated with use.
During the study year, 36% of the depressed patients filled a benzodiazepine prescription and 89% filled an antidepressant prescription. Most users (78%) received > or = 90 days' supply of benzodiazepines, and 61% received > or = 180 days' supply. Older patients, whites, Hispanics, and patients with comorbid anxiety disorders were more likely to use benzodiazepines. Older patients were also more likely to receive > or = 90 days' supply of benzodiazepines, compared with younger patients, but were treated with lower doses. Benzodiazepine use varied significantly with region of the country and facility.
Depressed patients treated in mental health settings commonly receive long-term treatment with benzodiazepines in combination with antidepressants, a pattern of use that is inconsistent with guideline recommendations. Elderly patients are particularly likely to receive benzodiazepines. Further research on the effectiveness of this widespread practice is needed.
大多数抑郁症治疗指南强调使用抗抑郁药物进行治疗,并建议尽量减少苯二氮䓬类药物的使用,尤其是在老年患者中。然而,对于在专科心理健康机构中苯二氮䓬类药物的使用模式知之甚少。作者调查了在美国退伍军人事务部(VA)心理健康机构接受治疗的大量抑郁症患者中苯二氮䓬类药物的使用情况。
利用VA抑郁症国家登记处来确定在2001财年第一季度(2000年10月1日至12月31日)129个VA机构的专科心理健康机构中接受抑郁症治疗的患者(N = 128,029)。使用VA药房数据库来确定开具了苯二氮䓬类药物处方的门诊患者。作者报告了研究年度(2001财年)门诊苯二氮䓬类药物使用的患病率和模式,并评估了与使用相关的患者人口统计学和临床因素。
在研究年度,36%的抑郁症患者开具了苯二氮䓬类药物处方,89%的患者开具了抗抑郁药物处方。大多数使用者(78%)获得了≥90天的苯二氮䓬类药物供应,61%的使用者获得了≥180天的供应。老年患者、白人、西班牙裔以及患有共病焦虑症的患者更有可能使用苯二氮䓬类药物。与年轻患者相比,老年患者也更有可能获得≥90天的苯二氮䓬类药物供应,但使用的剂量较低。苯二氮䓬类药物的使用在该国不同地区和机构之间存在显著差异。
在心理健康机构接受治疗的抑郁症患者通常会接受苯二氮䓬类药物与抗抑郁药物联合的长期治疗,这种使用模式与指南建议不一致。老年患者尤其有可能接受苯二氮䓬类药物治疗。需要对这种广泛做法的有效性进行进一步研究。